课题基金 / 基金详情

AIM-HIGH CAROTID MRI STUDY

AIM-HIGH CAROTID MRI STUDY
AIM-高颈动脉 MRI 研究
批准号:
8167035
负责人:
JOHN R CROUSE
金额:
$3.35万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-03-01 至 2011-02-28

项目摘要

项目成果

JOHN R CROUSE的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金, 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 AIM-HIGH MRI亚研究将提供体内无创性量化增加高密度脂蛋白对颈动脉大小和成分的影响。这些动脉水平的影响将与临床结果进行比较,如心肌梗死、中风和冠心病死亡。这些比较将使我们能够评估MRI作为临床试验的非侵入性终点。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The AIM-HIGH MRI Substudy will provide non-invasive in vivo quantification of the effect of increasing HDL on carotid artery dimensions and composition. These artery level effects will be compared to clinical outcomes such as MI, stroke and CHD death as well. These comparsions will allow us to evaluate MRI as a non-invasive endpoint for clinical trials.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CLINICAL TRIAL: AIM-HIGH: ATHEROSCLEROSIS INTERVENTIONIN MATABOLIC SYNDROME WIT
CLINICAL TRIAL: ACTION TO CONTROL CARDIOVASCULAR RISKS IN DIABETES (ACCORD)
CLINICAL TRIAL: ACTION TO CONTROL CARDIOVASCULAR RISKS IN DIABETES (ACCORD)
AIM-HIGH CAROTID MRI STUDY
海外基金